<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01471496</url>
  </required_header>
  <id_info>
    <org_study_id>konuk-001</org_study_id>
    <nct_id>NCT01471496</nct_id>
  </id_info>
  <brief_title>Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers</brief_title>
  <official_title>Prophylactic Injection Therapy Reduces Recurrent Bleeding Rate In Forrest Type IIb Duodenal Ulcer Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bakirkoy Dr. Sadi Konuk Research and Training Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bakirkoy Dr. Sadi Konuk Research and Training Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether prophylactic injection therapy reduces
      recurrent bleeding rate for duodenal ulcers which has the endoscopic stigmata of recent
      bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The benefit of endoscopic therapy in ulcers with adherent clots on their surface is still
      uncertain. A prophylactic injection therapy may reduce the recurrent bleeding rate at this
      group of patients having this endoscopic stigma of recent bleeding. This type of ulcers are
      named as type IIb duodenal ulcers according to Forrest's classification, They cary the risk
      of bleeding recurrence up to 36 percent and as it is reported previously there may be a 12
      fold increasement in morbidity and mortality in such cases. A prophylactic endoscopic
      injection therapy may reduce the risk of recurrent bleeding in this group of the patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of clinically definitive recurrent bleeding confirmed by upper gastrointestinal system endoscopy or surgery.</measure>
    <time_frame>within first two days after index endoscopy</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Duodenal Ulcer Bleeding</condition>
  <arm_group>
    <arm_group_label>prophylactic injection therapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to medical therapy which included 2x 30 mg Pantoprazole and intravenous fluids this group of the patients recieved injection therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group of the patients recieved medical therapy only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prophylactic injection therapy</intervention_name>
    <description>Standard application of endoscopic injection therapy as it is used for actively bleeding ulcers, 10 ml of serum saline with 1/10000 epinephrine is submucosally injected to the four quadrants of the ulcer margins.</description>
    <arm_group_label>prophylactic injection therapy group</arm_group_label>
    <other_name>prophylactic sclerotherapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endoscopic diagnose of Forrest type 2b duodenal ulcer.

        Exclusion Criteria:

          -  Patients at whom the onset of Upper Gastrointestinal system bleeding symptoms exceeded
             24 hours at index endoscopy.

          -  Patients having hemodynamic instability: systolic blood pressure below 90 mm/hg, heart
             rate above 110/min

          -  Demonstration of hemoglobin fall more than 2 g/dl in two hours.

          -  Patients with coexisting ulcers elsewhere than in duodenum.

          -  Patients under anticoagulant therapy other than Aspirin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osman Z Öner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of General Surgery, Istanbul, Turkey</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of General Surgery</name>
      <address>
        <city>Istanbul</city>
        <zip>34147</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Cheung FK, Lau JY. Management of massive peptic ulcer bleeding. Gastroenterol Clin North Am. 2009 Jun;38(2):231-43. doi: 10.1016/j.gtc.2009.03.003. Review.</citation>
    <PMID>19446256</PMID>
  </reference>
  <reference>
    <citation>Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc. 2008 Mar;67(3):422-9. doi: 10.1016/j.gie.2007.09.024. Epub 2008 Jan 18.</citation>
    <PMID>18206878</PMID>
  </reference>
  <reference>
    <citation>Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol. 1995 Apr;90(4):568-73.</citation>
    <PMID>7717312</PMID>
  </reference>
  <reference>
    <citation>Pilotto A, Maggi S, Noale M, Franceschi M, Parisi G, Crepaldi G; IPOD Investigators. Development and validation of a new questionnaire for the evaluation of upper gastrointestinal symptoms in the elderly population: a multicenter study. J Gerontol A Biol Sci Med Sci. 2010 Feb;65(2):174-8. doi: 10.1093/gerona/glp073. Epub 2009 Jun 15.</citation>
    <PMID>19528359</PMID>
  </reference>
  <reference>
    <citation>Cappell MS, Friedel D. Initial management of acute upper gastrointestinal bleeding: from initial evaluation up to gastrointestinal endoscopy. Med Clin North Am. 2008 May;92(3):491-509, xi. doi: 10.1016/j.mcna.2008.01.005. Review.</citation>
    <PMID>18387374</PMID>
  </reference>
  <reference>
    <citation>Kovacs TO. Management of upper gastrointestinal bleeding. Curr Gastroenterol Rep. 2008 Dec;10(6):535-42. Review.</citation>
    <PMID>19006607</PMID>
  </reference>
  <reference>
    <citation>Kubba AK, Palmer KR. Role of endoscopic injection therapy in the treatment of bleeding peptic ulcer. Br J Surg. 1996 Apr;83(4):461-8. Review.</citation>
    <PMID>8665233</PMID>
  </reference>
  <reference>
    <citation>Chung SC, Leung JW, Leung FW. Effect of submucosal epinephrine injection on local gastric blood flow. A study using laser Doppler flowmetry and reflectance spectrophotometry. Dig Dis Sci. 1990 Aug;35(8):1008-11.</citation>
    <PMID>2384031</PMID>
  </reference>
  <reference>
    <citation>Calvet X, Vergara M, Brullet E, Gisbert JP, Campo R. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology. 2004 Feb;126(2):441-50. Review.</citation>
    <PMID>14762781</PMID>
  </reference>
  <reference>
    <citation>Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978 Jan;74(1):38-43.</citation>
    <PMID>21830</PMID>
  </reference>
  <reference>
    <citation>Heldwein W, Schreiner J, Pedrazzoli J, Lehnert P. Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers? Endoscopy. 1989 Nov;21(6):258-62.</citation>
    <PMID>2693077</PMID>
  </reference>
  <reference>
    <citation>Ferguson CB, Mitchell RM. Non-variceal upper gastrointestinal bleeding. Ulster Med J. 2006 Jan;75(1):32-9. Review.</citation>
    <PMID>16457402</PMID>
  </reference>
  <reference>
    <citation>Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974 Aug 17;2(7877):394-7.</citation>
    <PMID>4136718</PMID>
  </reference>
  <reference>
    <citation>Peter S, Wilcox CM. Modern endoscopic therapy of peptic ulcer bleeding. Dig Dis. 2008;26(4):291-9. doi: 10.1159/000177011. Epub 2009 Jan 30. Review.</citation>
    <PMID>19188717</PMID>
  </reference>
  <reference>
    <citation>Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987 May;28(5):527-32.</citation>
    <PMID>3596334</PMID>
  </reference>
  <reference>
    <citation>Balanzó J, Sainz S, Such J, Espinós JC, Guarner C, Cussó X, Monés J, Vilardell F. Endoscopic hemostasis by local injection of epinephrine and polidocanol in bleeding ulcer. A prospective randomized trial. Endoscopy. 1988 Nov;20(6):289-91.</citation>
    <PMID>3068050</PMID>
  </reference>
  <reference>
    <citation>Buffoli F, Graffeo M, Nicosia F, Gentile C, Cesari P, Rolfi F, Paterlini A. Peptic ulcer bleeding: comparison of two hemostatic procedures. Am J Gastroenterol. 2001 Jan;96(1):89-94.</citation>
    <PMID>11197294</PMID>
  </reference>
  <reference>
    <citation>Hui WM, Ng MM, Lok AS, Lai CL, Lau YN, Lam SK. A randomized comparative study of laser photocoagulation, heater probe, and bipolar electrocoagulation in the treatment of actively bleeding ulcers. Gastrointest Endosc. 1991 May-Jun;37(3):299-304.</citation>
    <PMID>2070978</PMID>
  </reference>
  <reference>
    <citation>Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology. 1992 Jan;102(1):139-48.</citation>
    <PMID>1530782</PMID>
  </reference>
  <reference>
    <citation>Branicki FJ, Coleman SY, Fok PJ, Pritchett CJ, Fan ST, Lai EC, Mok FP, Cheung WL, Lau PW, Tuen HH, et al. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg. 1990 Mar-Apr;14(2):262-9; discussion 269-70.</citation>
    <PMID>2327100</PMID>
  </reference>
  <reference>
    <citation>Cooper GS, Chak A, Way LE, Hammar PJ, Harper DL, Rosenthal GE. Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay. Gastrointest Endosc. 1999 Feb;49(2):145-52.</citation>
    <PMID>9925690</PMID>
  </reference>
  <reference>
    <citation>Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009 Jan;7(1):33-47; quiz 1-2. doi: 10.1016/j.cgh.2008.08.016. Epub 2008 Aug 16.</citation>
    <PMID>18986845</PMID>
  </reference>
  <reference>
    <citation>Kahi CJ, Jensen DM, Sung JJ, Bleau BL, Jung HK, Eckert G, Imperiale TF. Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology. 2005 Sep;129(3):855-62. Erratum in: Gastroenterology. 2006 Sep;131(3):980-1.</citation>
    <PMID>16143125</PMID>
  </reference>
  <reference>
    <citation>Marmo R, Rotondano G, Bianco MA, Piscopo R, Prisco A, Cipolletta L. Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis. Gastrointest Endosc. 2003 Jan;57(1):62-7.</citation>
    <PMID>12518133</PMID>
  </reference>
  <reference>
    <citation>Laine L, Stein C, Sharma V. A prospective outcome study of patients with clot in an ulcer and the effect of irrigation. Gastrointest Endosc. 1996 Feb;43(2 Pt 1):107-10.</citation>
    <PMID>8635701</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2011</study_first_submitted>
  <study_first_submitted_qc>November 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2011</study_first_posted>
  <last_update_submitted>November 10, 2011</last_update_submitted>
  <last_update_submitted_qc>November 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>duodenal ulcer</keyword>
  <keyword>upper gastrointestinal system bleeding</keyword>
  <keyword>injection therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Duodenal Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

